Avid Bioservices Inc (CDMO)

[tech0200]

While that may be true if they have changed their tune and demanding accountability from the new BOD that is a good thing.

If there was no Phase II sabotage or Phase III outperforming control arm and Bavi had been approved we would have all been fine. Those are two things that no one predicted. There was definitely high hope before the first look in. But we can all agree that the old BOD should have partnered and not go at it alone. We don't know if there would have been a similar result at the first look in with partner.

I don't understand how the FDA would allow a trial to be tainted by allowing patients who went on to a different drug to be still be counted in the control arm. Those patients should not have been counted because SUNRISE was comparing Bavi plus Doce against Doce alone. Maybe the great Garnick should have foreseen this and demand that in the event some patients pursue a different treatment they should be excluded from being in the control arm.

I think as patients or potential patient we want as many options as possible. Now there is no option of Bavi and Doce.